A study observed that while TXA showed a trend toward reducing transfusion requirements in cerebral palsy patients undergoing hip reconstruction, this effect does not reach statistical significance. 20 Besides, a matched comparative study indicated no significant differences in postoperative Hb levels, hospitalization duration, or transfusion rates between the TXA and control groups in children undergoing bony reconstruction for neuromuscular hip dysplasia. 21 These conflicting results suggest that the universal clinical benefits of TXA still require further validation.
← all excerpts
Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study.
1
—
—